82C Stock Overview
NIOX Group Plc, a diagnostics and management company, provides point-of-care fractional exhaled nitric oxide (FeNo) diagnosis and management products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
NIOX Group Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.40 |
| 52 Week High | UK£0.53 |
| 52 Week Low | UK£0.28 |
| Beta | 1.28 |
| 1 Month Change | 12.29% |
| 3 Month Change | 0.50% |
| 1 Year Change | -24.15% |
| 3 Year Change | 27.62% |
| 5 Year Change | -63.12% |
| Change since IPO | -88.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| 82C | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -9.5% | 2.0% | -0.9% |
| 1Y | -24.2% | 14.1% | -9.6% |
Return vs Industry: 82C underperformed the German Biotechs industry which returned 13.9% over the past year.
Return vs Market: 82C underperformed the German Market which returned -8.7% over the past year.
Price Volatility
| 82C volatility | |
|---|---|
| 82C Average Weekly Movement | 6.4% |
| Biotechs Industry Average Movement | 5.4% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 82C is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 82C's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 111 | n/a | https://investors.niox.com |
NIOX Group Plc, a diagnostics and management company, provides point-of-care fractional exhaled nitric oxide (FeNo) diagnosis and management products worldwide. Its products include NIOX VERO, a portable system for the non-invasive measurement of nitric oxide in human breath. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022.
NIOX Group Plc Fundamentals Summary
| 82C fundamental statistics | |
|---|---|
| Market Cap | €185.44m |
| Earnings (TTM) | €14.96m |
| Revenue (TTM) | €32.65m |
12.4x
P/E Ratio5.7x
P/S RatioIs 82C overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 82C income statement (TTM) | |
|---|---|
| Revenue | UK£28.80m |
| Cost of Revenue | UK£8.70m |
| Gross Profit | UK£20.10m |
| Other Expenses | UK£6.90m |
| Earnings | UK£13.20m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Mar 21, 2023
| Earnings per share (EPS) | 0.031 |
| Gross Margin | 69.79% |
| Net Profit Margin | 45.83% |
| Debt/Equity Ratio | 0% |
How did 82C perform over the long term?
See historical performance and comparison